The Hartford Healthcare FundHGHRX
Type
Mutual fund
Peer group
US equity: Healthcare
Net assets
$729.2M
Expense ratio
1.66%
1-year return
+11.5%
3 years, a year
+4.3%
5 years, a year
+1.0%
Holdings
85
What it aims to do.
The Fund seeks long-term capital appreciation.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| LLY Eli Lilly & Co | 12.11% |
| MRK Merck & Co Inc | 6.30% |
| JNJ Johnson & Johnson | 5.80% |
| UNH UnitedHealth Group Inc | 5.54% |
| ISRG Intuitive Surgical Inc | 3.62% |
| ABBV AbbVie Inc | 3.09% |
| ABT Abbott Laboratories | 2.79% |
| DHR Danaher Corp | 2.68% |
| EW Edwards Lifesciences Corp | 2.54% |
| CVS CVS Health Corp | 2.44% |
More on HGHRX.
- HGHRX overview
- HGHRX holdings
- HGHRX risk
- HGHRX costs
- HGHRX money in and out
- HGHRX share classes
- Compare HGHRX with other funds
Returns after fees, from the fund's SEC filings up to Apr 2026. Past returns are not a promise. Not financial advice.